Genertec Universal Medical Group Company Limited

SEHK:2666 Voorraadrapport

Marktkapitalisatie: HK$9.4b

Genertec Universal Medical Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Genertec Universal Medical Group has a total shareholder equity of CN¥22.3B and total debt of CN¥50.1B, which brings its debt-to-equity ratio to 224.9%. Its total assets and total liabilities are CN¥84.0B and CN¥61.7B respectively.

Belangrijke informatie

224.9%

Verhouding schuld/eigen vermogen

CN¥50.14b

Schuld

Rente dekkingsration/a
ContantCN¥2.55b
AandelenCN¥22.29b
Totaal verplichtingenCN¥61.68b
Totaal activaCN¥83.97b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price

Oct 09
Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

May 10
Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Feb 05
Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Jun 08
Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 08
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 31
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Aug 20
Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Apr 19
Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Mar 10
Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Feb 19
Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

Feb 01
Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

Jan 11
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Dec 21
What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Nov 30
Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Analyse van de financiële positie

Kortlopende schulden: 2666's short term assets (CN¥75.0B) exceed its short term liabilities (CN¥25.6B).

Langlopende schulden: 2666's short term assets (CN¥75.0B) exceed its long term liabilities (CN¥36.1B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 2666's net debt to equity ratio (213.5%) is considered high.

Schuld verminderen: 2666's debt to equity ratio has reduced from 324.8% to 224.9% over the past 5 years.

Schuldendekking: 2666's debt is not well covered by operating cash flow (12.7%).

Rentedekking: Insufficient data to determine if 2666's interest payments on its debt are well covered by EBIT.


Balans


Ontdek gezonde bedrijven